|
|
2003 Hormonal Carcinogenesis Gordon Research Conference
|
5R13CA101813-03
|
$5,000
|
$500
|
BOSLAND, MAARTEN
|
GORDON RESEARCH CONFERENCES
|
|
|
2006 Glycolipid & Sphingolipid Gordon Conference
|
3R13CA119831-01S1
|
$15,000
|
$3,750
|
MERRILL, ALFRED
|
GORDON RESEARCH CONFERENCES
|
|
|
25-hydroxy-D3 as a possible chemopreventive agent for breast cancer
|
5R03CA121365-02
|
$91,634
|
$91,634
|
Peng, Xinjian
|
IIT RESEARCH INSTITUTE
|
|
|
5-LOX-1 and Clinical Chemoprevention of Colon Tumors
|
5R01CA106577-03
|
$280,899
|
$280,899
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
5th International Symposium on the Intraductal Approach to Breast Cancer
|
1R13CA128385-01
|
$11,000
|
$5,500
|
Love, Susan
|
DR. SUSAN LOVE RESEARCH FOUNDATION
|
|
|
A Biomarker Study of COX-2 Inhibitors in IPMN
|
5R03CA112629-02
|
$73,553
|
$73,553
|
Schmidt, Christian
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
A Drosophila model for the electrophile counter-attack chemoprevention strategy
|
5R03CA123591-02
|
$74,767
|
$74,767
|
BOHMANN, DIRK
|
UNIVERSITY OF ROCHESTER
|
|
|
A molecular target for nutrients in the prostate
|
5R01CA100994-05
|
$287,763
|
$287,763
|
LASKIN, JEFFREY
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
A Mouse Model for Prostate Cancer
|
5U01CA084294-09
|
$1,212,233
|
$606,117
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
A new method for delivery of selinium for prevention of melanoma
|
5R03CA125854-02
|
$72,582
|
$72,582
|
Cassidy, Pamela
|
UNIVERSITY OF UTAH
|
|
|
A novel mouse colon cancer model and chemoprevention
|
3R01CA113349-01A2S1
|
$20,000
|
$20,000
|
DAI, WEI
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
A novel mouse colon cancer model and chemoprevention
|
5R01CA113349-02
|
$295,185
|
$295,185
|
DAI, WEI
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
A novel sulindac derivative for colon cancer chemoprevention
|
1R03CA128021-01
|
$108,011
|
$108,011
|
PIAZZA, GARY
|
SOUTHERN RESEARCH INSTITUTE
|
|
|
A Novel Vitamin D Target in Human Prostate Cancer
|
5R21CA113380-02
|
$113,523
|
$113,523
|
BEER, TOMASZ
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
A Pilot Trial of Oral Melatonin Supplementation in Breast Cancer Survivors
|
5R03CA123597-02
|
$84,574
|
$84,574
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Aberrant Crypt Foci as a Biomarker for Chemoprevention
|
5R01CA113681-02
|
$462,908
|
$462,908
|
SINICROPE, FRANK
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
$2,152
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
$72,823
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Action of Novel Retinyl Ethers in Breast Cancer Control
|
5R01CA108498-04
|
$281,848
|
$281,848
|
SANI, BRAHMA
|
CHEMOPREVENTIA, LLC
|
|
|
Acylation as an Approach to Enhance the Cancer Preventive Effect of EGCG
|
5R03CA121390-02
|
$75,010
|
$75,010
|
Sang, Shengmin
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
|
|
Altered Arachidonic Acid Balance and Colon Cancer
|
5R01CA114635-02
|
$305,945
|
$152,973
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
ANALOG STUDIES OF 4-HPR AND ITS GLUCURONIDE
|
5R01CA049837-14
|
$282,094
|
$282,094
|
CURLEY, ROBERT
|
OHIO STATE UNIVERSITY
|
|
|
Analysis of Apigenin in Inhibiting Ovarian Tumorigenesis
|
5R03CA123675-02
|
$71,126
|
$71,126
|
JIANG, BING-HUA
|
WEST VIRGINIA UNIVERSITY
|
|
|
Angioprevention of Lung Tumorigenesis by Silibinin
|
5R01CA113876-03
|
$283,140
|
$283,140
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
|
Animal Model for Local Inflammation-Induced Breast Cancer
|
1R03CA117486-01A1
|
$75,750
|
$75,750
|
NAKSHATRI, HARIKRISHNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
Annual San Antonio Breast Cancer Symposium
|
5R13CA119860-02
|
$5,000
|
$500
|
COLTMAN, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
|
Annual Uterine Cancer Symposium
|
5R13CA113095-04
|
$5,971
|
$597
|
LU, KAREN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Anticarcinogenic Effect of ITCs Against Prostate Cancer
|
5R01CA101753-05
|
$312,472
|
$312,472
|
Singh, Shivendra
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Anticarcinogenic Mechanisms of Tea Constituents
|
5R01CA081064-08
|
$267,387
|
$267,387
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
Antioxidant Interactions with Prostate Cancer Treatments
|
5R21CA102386-02
|
$161,060
|
$161,060
|
Shiverick, Kathleen
|
UNIVERSITY OF FLORIDA
|
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
5R01CA116468-03
|
$251,966
|
$75,590
|
JONES, DAVID
|
UNIVERSITY OF UTAH
|
|
|
APC mutation and breast cancer: Prevention by curcumin
|
5R01CA122394-02
|
$289,553
|
$289,553
|
Katdare, Meena
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
|
Apoptotic mechanisms in NSAID chemoprevention
|
5R01CA109012-03
|
$251,966
|
$251,966
|
Dambrosio, Steven
|
OHIO STATE UNIVERSITY
|
|
|
Applications of New Mass Spectral Techniques
|
Z01 BC 006178
|
$276,750
|
$27,675
|
Kelley, James
|
CCR (NCI)
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$178,023
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$55,481
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$160,663
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$43,204
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$2,020,958
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Aspirin use, genetic variation in aspirin related-genes, and Hodgkin lymphoma ris
|
1R03CA130048-01
|
$72,500
|
$72,500
|
Chang, Ellen
|
NORTHERN CALIFORNIA CANCER CENTER
|
|
|
Aspirin/Folate Prevention of Large Bowel Polyps
|
5R01CA059005-14
|
$605,742
|
$605,742
|
BARON, JOHN
|
DARTMOUTH COLLEGE
|
|
|
Assessing the Impact of Colorectal Cancer Screening
|
5U01CA097427-06
|
$213,789
|
$74,826
|
RUTTER, CAROLYN
|
CENTER FOR HEALTH STUDIES
|
|
|
Atlanta Regional Community Clinical Oncology Program
|
5U10CA045450-21
|
$623,000
|
$49,840
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
Barrett's Esophagus: Predictors of Progression
|
2P01CA091955-06
|
$2,428,948
|
$242,895
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$38,400
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$5,585
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-06
|
$1,030,000
|
$82,400
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
Bioactive Food Comoponents, Alternative Medicine and Cancer Chemoprevention: Rece
|
1R13CA132241-01
|
$12,000
|
$12,000
|
Singh, Shivendra
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Biology of the Prostate Cancer Prevention Trial (PCPT)
|
5P01CA108964-03
|
$2,991,992
|
$2,991,992
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Total relevant funding to Chemoprevention for this search: $184,297,242
|
